PATIENT SELECTION FOR SERUM GENTAMICIN LEVELS

被引：2

作者：

LAMPASONA, V

CRASS, RE

机构：

[1] MED UNIV S CAROLINA,DEPT CLIN & INST PHARM,CLIN PHARMACOKINET SERV,CHARLESTON,SC 29425

[2] EMORY UNIV,DEPT HOSP PHARM,ATLANTA,GA 30322

来源：

THERAPEUTIC DRUG MONITORING | 1983年 / 5卷 / 03期

关键词：

D O I：

10.1097/00007691-198309000-00004

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：255 / 262

页数：8

共 43 条

[1]

ANDERSON AC, 1976, ARCH INTERN MED, V136, P785

[2] PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN [J].

BARZA, M ;

BROWN, RB ;

SHEN, D ;

GIBALDI, M ;

WEINSTEIN, L .

JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) :165-174

[3] WHY MONITOR SERUM LEVELS OF GENTAMICIN [J].

BARZA, M ;

LAUERMANN, M .

CLINICAL PHARMACOKINETICS, 1978, 3 (03) :202-215

[4]

Blackburn G L, 1977, JPEN J Parenter Enteral Nutr, V1, P11, DOI 10.1177/014860717700100111

[5]

BODEY GP, 1972, CANCER-AM CANCER SOC, V29, P1697, DOI 10.1002/1097-0142(197206)29:6<1697::AID-CNCR2820290638>3.0.CO

[6]

2-K

[7] GENTAMICIN PHARMACOKINETICS IN KWASHIORKOR [J].

BUCHANAN, N ;

DAVIS, MD ;

EYBERG, C .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (05) :451-453

[8] NEPHROTOXICITY OF AMPHOTERICIN B - EARLY + LATE EFFECTS IN 81 PATIENTS [J].

BUTLER, WT ;

BENNETT, JE ;

WERTLAKE, PT ;

UTZ, JP ;

ALLING, DW ;

HILL, GJ .

ANNALS OF INTERNAL MEDICINE, 1964, 61 (02) :175-+

[9] PREDICTION OF GENTAMICIN SERUM LEVELS USING A ONE-COMPARTMENT OPEN LINEAR PHARMACOKINETIC MODEL [J].

CHOW, M ;

DEGLIN, J ;

HARRALSON, A ;

BARTLETT, R ;

QUINTILIANI, R .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (09) :1078-1081

[10] MODEL FOR PROSPECTIVE IDENTIFICATION OF PRE-NEPHROTOXIC STATE DURING GENTAMICIN THERAPY [J].

COLBURN, WA ;

SCHENTAG, JJ ;

JUSKO, WJ ;

GIBALDI, M .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (03) :179-186

← 1 2 3 4 5 →